leading biotech company for glp-1 A brewing showdown, from Big Pharma pills to a implant Weight-Loss Drugs Are Everywhere Now.

Knowing how your body reacts is important to avoid gaining the weight back again

The LEADER trial showed that liraglutide reduced the risk of major cardiovascular events in people with type 2 diabetes.[4] Soon after, SUSTAIN-6 demonstrated similar benefits with semaglutide.[5] Then came REWIND, which suggested that cardiovascular protection could extend even to patients without established cardiovascular disease.[6] The SELECT trial made headlines because it showed cardiovascular benefits in people with overweight or obesity who did not have diabetes, a finding that challenged long-held assumptions about who might benefit from these medicines.[7] Most recently, an international trial called SOUL, which tested an oral form of semaglutide, included 788 Indian patients across 32 centres

Dual blockade of the homeostatic chemokine CXCL12 and the proinflammatory chemokine CCL2 has additive protective effects on diabetic kidney disease

Your body knows what it needs 3

With decreased gastric emptying and increased satiety, a common pharmacological effect observed when conducting these studies is a decrease in food consumption and body weight loss